P Adlard

1.0k total citations
16 papers, 709 citations indexed

About

P Adlard is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Endocrine and Autonomic Systems. According to data from OpenAlex, P Adlard has authored 16 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in P Adlard's work include Growth Hormone and Insulin-like Growth Factors (6 papers), Prion Diseases and Protein Misfolding (5 papers) and Thyroid Disorders and Treatments (3 papers). P Adlard is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (6 papers), Prion Diseases and Protein Misfolding (5 papers) and Thyroid Disorders and Treatments (3 papers). P Adlard collaborates with scholars based in United Kingdom, India and Italy. P Adlard's co-authors include Anthony J. Swerdlow, C Higgins, Michael A. Preece, Lesley Rees, Stephen A. Greene, C Chantler, G B Haycock, Michael Preece, J. Jones and Fabio Buzi and has published in prestigious journals such as The Lancet, Brain and Neurology.

In The Last Decade

P Adlard

15 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Adlard United Kingdom 12 313 306 139 114 97 16 709
Ana Pinheiro Machado Canton Brazil 18 291 0.9× 167 0.5× 85 0.6× 119 1.0× 20 0.2× 37 894
Thérèse Lemarchand-Béraud Switzerland 17 147 0.5× 512 1.7× 83 0.6× 78 0.7× 6 0.1× 27 957
Woo Yeong Chung South Korea 10 132 0.4× 147 0.5× 51 0.4× 103 0.9× 15 0.2× 47 417
M. Yanagisawa Japan 11 146 0.5× 325 1.1× 24 0.2× 61 0.5× 13 0.1× 28 623
Markus Langkamp Germany 12 172 0.5× 215 0.7× 74 0.5× 76 0.7× 49 0.5× 16 532
M. Lundqvist Sweden 15 110 0.4× 153 0.5× 52 0.4× 92 0.8× 10 0.1× 40 532
Ganesh Chauhan India 16 240 0.8× 128 0.4× 42 0.3× 87 0.8× 33 0.3× 28 769
Neva J. Fudge Canada 14 174 0.6× 49 0.2× 94 0.7× 32 0.3× 32 0.3× 23 681
Ja Hye Kim South Korea 15 239 0.8× 89 0.3× 53 0.4× 86 0.8× 8 0.1× 68 553
Irene Martín‐Estal Mexico 11 120 0.4× 93 0.3× 79 0.6× 71 0.6× 13 0.1× 22 397

Countries citing papers authored by P Adlard

Since Specialization
Citations

This map shows the geographic impact of P Adlard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Adlard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Adlard more than expected).

Fields of papers citing papers by P Adlard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Adlard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Adlard. The network helps show where P Adlard may publish in the future.

Co-authorship network of co-authors of P Adlard

This figure shows the co-authorship network connecting the top 25 collaborators of P Adlard. A scholar is included among the top collaborators of P Adlard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Adlard. P Adlard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ritchie, Diane, P Adlard, Alexander Peden, et al.. (2017). Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK. Acta Neuropathologica. 134(2). 221–240. 71 indexed citations
2.
Ritchie, Diane, Marcelo A. Barria, Alexander Peden, et al.. (2016). UK Iatrogenic Creutzfeldt–Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches. Acta Neuropathologica. 133(4). 579–595. 28 indexed citations
3.
Rudge, Peter, Zane Jaunmuktane, P Adlard, et al.. (2015). Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain. 138(11). 3386–3399. 61 indexed citations
4.
Ahmad, Imran, Wendy F. Paterson, Lin Lin, et al.. (2007). A Novel Missense Mutation in Dax-1 with an Unusual Presentation of X-Linked Adrenal Hypoplasia Congenita. Hormone Research in Paediatrics. 68(1). 32–37. 20 indexed citations
5.
Preece, M A, Anthony J. Swerdlow, C Higgins, & P Adlard. (2003). Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: A cohort study. 5.
6.
Swerdlow, Anthony J., C Higgins, P Adlard, Michael E. Jones, & Michael A. Preece. (2003). Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology. 61(6). 783–791. 47 indexed citations
7.
Hall, Michael E., et al.. (2002). Early cognitive decline in Creutzfeldt-Jakob disease occurring in recipients of pituitary-derived human growth hormone. UCL Discovery (University College London). 1 indexed citations
8.
Swerdlow, Anthony J., et al.. (2002). Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study. The Lancet. 360(9329). 273–277. 210 indexed citations
9.
Buzi, Fabio, et al.. (1998). Pelvic ultrasonography in normal girls and in girls with pubertal precocity. Acta Paediatrica. 87(11). 1138–1145. 72 indexed citations
10.
Stanhope, R, et al.. (1988). PHYSIOLOGICAL GROWTH HORMONE (GH) SECRETION DURING THE RECOVERY FROM PSYCHOSOCIAL DWARFISM: A CASE REPORT. Clinical Endocrinology. 28(4). 335–339. 25 indexed citations
11.
Buchanan, Charles, et al.. (1988). GONADOTROPHIN, GROWTH HORMONE AND PROLACTIN SECRETION IN CHILDREN WITH PRIMARY HYPOTHYROIDISM. Clinical Endocrinology. 29(4). 427–436. 28 indexed citations
12.
Rees, Lesley, Stephen A. Greene, P Adlard, et al.. (1988). Growth and endocrine function in steroid sensitive nephrotic syndrome.. Archives of Disease in Childhood. 63(5). 484–490. 66 indexed citations
13.
Rees, Lesley, Stephen A. Greene, P Adlard, et al.. (1988). Growth and endocrine function after renal transplantation.. Archives of Disease in Childhood. 63(11). 1326–1332. 64 indexed citations
14.
Buzi, Fabio, R Stanhope, J. Jones, P Adlard, & Michael A. Preece. (1988). SHORT SUBNORMALLY GROWING CHILDREN WITH NORMAL GH RESPONSE TO PHARMACOLOGICAL STIMULI: PHYSIOLOGICAL GH SECRETION AND RESPONSE TO GH TREATMENT. Pediatric Research. 23(1). 124–124. 1 indexed citations
15.
Buchanan, C R, et al.. (1988). GONADOTROPHIN, GROWTH HORMONE AND PROLACTIN SECRETORY DYSFUNCTION IN PRIMARY HYPOTHYROIDISM. Pediatric Research. 23(1). 133–133. 1 indexed citations
16.
Adlard, P, et al.. (1987). PHYSIOLOGICAL GROWTH HORMONE SECRETION DURING SLOW‐WAVE SLEEP IN SHORT PREPUBERTAL CHILDREN. Clinical Endocrinology. 27(3). 355–361. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026